Stockyfly One Page Analysis | Buy Stocks today

24/10/2025

Strides Pharma Science Ltd

BSE: 532531 NSE: STAR

Pharmaceuticals

Financial Health Score: 31%

About the Company

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in over 100 countries. The company has always followed an inorganic growth strategy over the years that resulted in foray into new markets, addition of new business segments, therapy segments and manufacturing infrastructure.

Pros

Company has reduced debt.
Company has delivered good profit growth of 89.9% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Company has been maintaining a healthy dividend payout of 114%

Cons

Company has low interest coverage ratio.
Promoter holding has decreased over last quarter: -0.44%
The company has delivered a poor sales growth of 4.81% over past five years.
Promoter holding is low: 27.9%
Promoters have pledged or encumbered 44.1% of their holding.
Company has high debtors of 248 days.
Working capital days have increased from 57.4 days to 82.8 days

Stock PE: 127

ROCE: 4.66

Market Cap: 7863 Cr.

Book Value: 346

ROE: 85.9

Face Value: 10

Credit Report: View PDF

STAR - Price Chart

Volume Chart

Last 30 Days Bulk Deals

SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark
1	STAR	Strides Pharma ScienceLtd	31/10/2025	GRAVITON RESEARCH CAPITAL LLP	SELL	578,738	939	-
2	STAR	Strides Pharma ScienceLtd	31/10/2025	GRAVITON RESEARCH CAPITAL LLP	BUY	578,738	937	-
SL#	Symbol	Name	Date	Client	Buy/Sell	Quantity	Price	Remark

Technical Indicators

Today's OPEN >= LOW and HIGH=CLOSE	No
Is a 7 Days Breakout ?	No
3 Days Consecutive Volume Spike:	No
2 Days Consecutive Price Hike:	No
Above 20 MA ?	Below
Above 50 MA ?	Below
Above 100 MA ?	Below
Above 200 MA ?	Above